GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $2.30 $3.29 Wednesday, 17th Apr 2024 ABUS stock ended at $2.78. This is 4.79% less than the trading day before Tuesday, 16th Apr 2024. During the day the stock fluctuated 5.67% from a day low at $2.78 to a day high of $2.94.
90 days $2.22 $3.29
52 weeks $1.69 $3.29

Historical Arbutus Biopharma Corporation prices

Date Open High Low Close Volume
2023-06-29 $2.23 $2.25 $2.19 $2.24 608 597
2023-06-28 $2.24 $2.29 $2.21 $2.25 1 147 466
2023-06-27 $2.28 $2.29 $2.23 $2.24 321 202
2023-06-26 $2.37 $2.39 $2.25 $2.26 943 616
2023-06-23 $2.46 $2.48 $2.38 $2.41 1 658 175
2023-06-22 $2.40 $2.51 $2.34 $2.47 962 470
2023-06-21 $2.42 $2.44 $2.34 $2.37 661 607
2023-06-20 $2.49 $2.49 $2.41 $2.44 505 963
2023-06-16 $2.48 $2.50 $2.42 $2.49 2 231 843
2023-06-15 $2.47 $2.47 $2.39 $2.44 691 525
2023-06-14 $2.50 $2.53 $2.45 $2.47 604 744
2023-06-13 $2.47 $2.51 $2.47 $2.50 626 707
2023-06-12 $2.45 $2.52 $2.44 $2.45 392 802
2023-06-09 $2.53 $2.56 $2.48 $2.48 478 841
2023-06-08 $2.62 $2.62 $2.51 $2.54 423 892
2023-06-07 $2.62 $2.67 $2.59 $2.62 464 352
2023-06-06 $2.59 $2.61 $2.55 $2.60 484 304
2023-06-05 $2.61 $2.64 $2.58 $2.60 219 323
2023-06-02 $2.54 $2.60 $2.50 $2.58 495 719
2023-06-01 $2.50 $2.55 $2.48 $2.50 309 983
2023-05-31 $2.47 $2.53 $2.47 $2.49 327 941
2023-05-30 $2.50 $2.56 $2.45 $2.47 371 202
2023-05-26 $2.50 $2.52 $2.47 $2.50 450 122
2023-05-25 $2.52 $2.54 $2.41 $2.50 1 005 925
2023-05-24 $2.65 $2.65 $2.54 $2.56 497 036
Click to get the best stock tips daily for free!

About Arbutus Biopharma Corporation

Arbutus Biopharma Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel ... ABUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT